Formula: | C24H29ClN2O3 |
Molecular Weight: | 428.96 |
Rotatable Bond Donors: | 4 |
clogP: | 4.24 |
Topological Polar Surface Area: | 61.80 |
Lipinski's RO5: | MW: 428.96 HBA: 5 HBD: 2 RB: 4 LogP: 4.24 |
Rule of Three: | MW: 428.96 HBA: 5 HBD: 2 RB: 4 LogP: 4.24 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC40424141 | 1.0 | ZINC40424141 RDKit 3D 29 32 0 0 0 0 0 0 0 0999 V2000 7.1869 0.1084 -1.5022 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6860 0.9870 -0.3794 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2442 1.0215 -0.3524 N 0 0 0 0 0 0 0 0 0 0 0 0 4.6382 2.2777 -0.7288 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3972 3.1526 0.4802 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5812 -0.0367 0.2544 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1817 -0.9712 0.7819 O 0 0 0 0 0 0 0 0 0 0 0 0 3.1021 -0.0590 0.2715 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3480 0.4829 -0.7675 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9583 0.3910 -0.7413 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3120 -0.2639 0.3114 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1523 -0.3591 0.3506 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8033 0.8112 0.3944 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2841 0.9511 0.5297 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5760 2.0842 1.4990 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5580 3.4275 0.8024 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5193 3.5342 -0.2868 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.0062 2.2400 -0.7438 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8840 1.2313 -0.8385 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9275 -0.2078 1.0840 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3471 -1.4178 0.8033 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.1829 -2.5272 0.9518 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7040 -3.8043 0.6859 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3897 -3.9709 0.2688 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5547 -2.8613 0.1426 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2857 -3.1049 -0.3004 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0028 -1.5639 0.4248 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0761 -0.8224 1.3399 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4658 -0.7301 1.3159 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 1 0 3 6 1 0 6 7 2 0 6 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 2 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 14 20 1 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 1 0 25 27 2 0 11 28 1 0 28 29 2 0 29 8 1 0 27 12 1 0 19 14 1 0 27 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |